Suven secures three product patents

Hyderabad, December 31, 2012: Suven Life Sciences has secured three product patents, two from Eurasia and one from Canada. It is worth noting here that the granted claims of the patents include the class of selective 5-HT compounds discovered by the Hyderabad-based company and were being developed as therapeutic agents.


The claims are also useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention Deficient Hyperactivity Disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia, as per a release issued by the company.


* Indicates mandatory field.
Please wait while comments are being sent...